Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection

NCT02464306 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT02464306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02464306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection
Lead sponsor
University of Colorado, Denver
Phase
Phase 4
Overall status
Withdrawn
Start date
June 30, 2018
Completion date
June 30, 2019
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection, solid organ transplant